Advanced Resin Therapeutics

ART has developed a novel resin-based drug delivery system that promotes topical and mucosal delivery of medications more effectively than current technologies.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location San Francisco, CA, US
  • Currency USD
  • Founded February 2016
  • Employees 3
  • Website advancedresin.com

Company Summary

The core technology is protected by a broad IP portfolio (11 issued, 28 pending patents). ART’s lead product opportunity is NicoSwab (previously RelievaDrop), a fast-acting, long-lasting nicotine replacement product that outperforms Nicorette in pre-clinical and phase 1 clinicals. NicoSwab acts approximately 2.5x faster and 2.5x longer than Nicorette. NicoSwab is ready for immediate market launch in the $2.4B smoking alternative marketplace.

Team

  • Howard Edelman

  • Tracey Forster
    Chief Marketing Officer

    Tracey Forster is a 20-year General Management and classically trained Marketing veteran with a track record of high growth by creating innovative strategies for consumer packaged goods, luxury and B2B SaaS companies. Tracey has held various marketing roles with GlaxoSmithKline, Johnson & Johnson and Estee Lauder. Tracey holds a B.S. in Marketing from the University of Florida.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free